Powder: -20°C for 3 years
In solvent: -80°C for 2 years
AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor ( IC 50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation.
Description | AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor ( IC 50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation. |
Targets&IC50 | VEGFR2:520 nM (IC50), FLT3:6 nM (IC50), CLK1:140 nM (IC50), RPS6KA:220 nM (IC50), FGFR2:1200 nM (IC50) |
In vitro | AKN-028 triggers apoptosis in MV4-11 by activation of caspase 3 [1] . AKN-028 (10 μM) is cytotoxic to AML cell lines and induces apoptosis in the AML cell line MV4-11 [1] . Cell Cytotoxicity Assay [1] Cell Line: AML cell line MV4-11. Concentration: 10 μM. Incubation Time: 24 h. Result: Was cytotoxic to primary AML cells, irrespective of FLT3 mutation status and quantitative FLT3 expression. |
In vivo | AKN-028 (15?mg/kg, Subcutaneously injection twice daily) exhibits anti-tumor activities for acute myeloid leukemia (AML) models [1] . Animal Model: Mice based AML and MV4-11 cells [1] . Dosage: 15?mg/kg. Administration: Subcutaneously injection twice daily. Result: Inhibited net growth of one of the primary AML samples (UPN26) in vivo and furthermore reduced the tumor mass of MV4-11 cell line. |
Molecular Weight | 302.33 |
Formula | C17H14N6 |
CAS No. | 1175017-90-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: <3.02 mg/mL (10 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AKN-028 1175017-90-9 Angiogenesis Tyrosine Kinase/Adaptors FLT inhibit Cluster of differentiation antigen 135 Inhibitor Fms like tyrosine kinase 3 Caspase acute myeloid leukemia CD135 AKN 028 Apoptosis FLT3 AKN028 AML cell lines cytotoxic FLT3 autophosphorylation inhibitor